Loading…

FUNCTIONAL PARTIAL AGONISM AT IONOTROPIC EXCITATORY AMINO ACID RECEPTORS

( RS)-2-Amino-3-(3-hydroxy-5-phenyl-4-isoxazolyl)propionic acid (APPA), which is an analogue of ( RS)-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid (AMPA), shows the characteristics of a partial AMPA receptor agonist. Since ( S)-APPA is a full AMPA agonist and ( R)-APPA a competitive ant...

Full description

Saved in:
Bibliographic Details
Published in:Neurochemistry international 1996-09, Vol.29 (3), p.309-316
Main Authors: EBERT, BJARKE, MADSEN, ULF, SØBY, KARINA K., KROGSGAARD-LARSEN, POVL
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c386t-8cb86873ba64ba1b5c5c23cee1adc119bf5a1ce936658700a0f94923b05caf8f3
cites
container_end_page 316
container_issue 3
container_start_page 309
container_title Neurochemistry international
container_volume 29
creator EBERT, BJARKE
MADSEN, ULF
SØBY, KARINA K.
KROGSGAARD-LARSEN, POVL
description ( RS)-2-Amino-3-(3-hydroxy-5-phenyl-4-isoxazolyl)propionic acid (APPA), which is an analogue of ( RS)-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid (AMPA), shows the characteristics of a partial AMPA receptor agonist. Since ( S)-APPA is a full AMPA agonist and ( R)-APPA a competitive antagonist, the partial agonism observed for APPA, which is a 1:1 mixture of ( S)- and ( R)-APPA, is only apparent. These observations have prompted comparative pharmacological studies of different molar ratios of a series of AMPA and N-methyl- d -aspartic acid (NMDA) agonists and respective competitive antagonists, and of these agonists in the presence of fixed concentrations of antagonist. Using the rat cortical wedge preparation, the latter series of experiments showed the expected rightward parallel shifts of the dose-response curves. The former type of experiments, on the other hand, produced dose-response curves at different levels of maximal response, depending on the molar ratios of agonist and antagonist used. This phenomenon, which is in agreement with the theory for competitive receptor interaction, has been termed functional partial agonism, a new pharmacological concept of potential therapeutic utility. These results were obtained using AMPA, the AMPA agonist ( RS)-2-amino-3-(5- tert-butyl-3-hydroxy-4-isoxazolyl)propionic acid (ATPA), the competitive AMPA antagonists ( RS-2-amino-3-(3-carboxymethoxy-5-methyl-4-isoxazolyl)propionic acid (AMOA) and 6-nitro-7-sulfamoylbenzo[ f] quinoxalin-2,3-dione (NBQX), NMDA, and the competitive NMDA antagonist ( RS)-3-(2-carboxy-4-piperazinyl)propyl-1-phosphonic acid (CPP). Copyright © 1996 Elsevier Science Ltd.
doi_str_mv 10.1016/0197-0186(95)00151-4
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78468358</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0197018695001514</els_id><sourcerecordid>78468358</sourcerecordid><originalsourceid>FETCH-LOGICAL-c386t-8cb86873ba64ba1b5c5c23cee1adc119bf5a1ce936658700a0f94923b05caf8f3</originalsourceid><addsrcrecordid>eNp9kNFKwzAUhoMoc07fQKEXInpRTdomTW6EUrutsLWj60CvQpqmUOnW2WyCb2_myi69OnD-7_wcPgBuEXxGEJEXiJhvQ0TJI8NPECKMbO8MDBH1HZv52DsHwxNyCa60_oQQ-gziARhQSrHD4BBMx6skzOM0CWbWIsjy2Mxgkibxcm4FuWWCNM_SRRxa0XsY50GeZh9WMI-T1ArC-M3KojBamOXyGlxUotHqpp8jsBpHeTi1Z-kkDoOZLV1KdjaVBSXUdwtBvEKgAkssHVcqhUQpEWJFhQWSirmEYOpDKGDFPOa4BcRSVLRyR-Dh2Lvt2q-90ju-rrVUTSM2qt1r7lOPUBdTA3pHUHat1p2q-Lar16L74Qjyg0B-sMMPdjjD_E8g98zZXd-_L9aqPB31xkx-3-dCS9FUndjIWp8wFxFqqgz2esSUcfFdq45rWauNVGXdKbnjZVv__8cvQnWFGQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78468358</pqid></control><display><type>article</type><title>FUNCTIONAL PARTIAL AGONISM AT IONOTROPIC EXCITATORY AMINO ACID RECEPTORS</title><source>ScienceDirect Freedom Collection</source><creator>EBERT, BJARKE ; MADSEN, ULF ; SØBY, KARINA K. ; KROGSGAARD-LARSEN, POVL</creator><creatorcontrib>EBERT, BJARKE ; MADSEN, ULF ; SØBY, KARINA K. ; KROGSGAARD-LARSEN, POVL</creatorcontrib><description>( RS)-2-Amino-3-(3-hydroxy-5-phenyl-4-isoxazolyl)propionic acid (APPA), which is an analogue of ( RS)-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid (AMPA), shows the characteristics of a partial AMPA receptor agonist. Since ( S)-APPA is a full AMPA agonist and ( R)-APPA a competitive antagonist, the partial agonism observed for APPA, which is a 1:1 mixture of ( S)- and ( R)-APPA, is only apparent. These observations have prompted comparative pharmacological studies of different molar ratios of a series of AMPA and N-methyl- d -aspartic acid (NMDA) agonists and respective competitive antagonists, and of these agonists in the presence of fixed concentrations of antagonist. Using the rat cortical wedge preparation, the latter series of experiments showed the expected rightward parallel shifts of the dose-response curves. The former type of experiments, on the other hand, produced dose-response curves at different levels of maximal response, depending on the molar ratios of agonist and antagonist used. This phenomenon, which is in agreement with the theory for competitive receptor interaction, has been termed functional partial agonism, a new pharmacological concept of potential therapeutic utility. These results were obtained using AMPA, the AMPA agonist ( RS)-2-amino-3-(5- tert-butyl-3-hydroxy-4-isoxazolyl)propionic acid (ATPA), the competitive AMPA antagonists ( RS-2-amino-3-(3-carboxymethoxy-5-methyl-4-isoxazolyl)propionic acid (AMOA) and 6-nitro-7-sulfamoylbenzo[ f] quinoxalin-2,3-dione (NBQX), NMDA, and the competitive NMDA antagonist ( RS)-3-(2-carboxy-4-piperazinyl)propyl-1-phosphonic acid (CPP). Copyright © 1996 Elsevier Science Ltd.</description><identifier>ISSN: 0197-0186</identifier><identifier>EISSN: 1872-9754</identifier><identifier>DOI: 10.1016/0197-0186(95)00151-4</identifier><identifier>PMID: 8885290</identifier><identifier>CODEN: NEUIDS</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Alanine - analogs &amp; derivatives ; Alanine - pharmacology ; Aminoacid receptors (glycine, glutamate, gaba) ; Animals ; Binding, Competitive - drug effects ; Biological and medical sciences ; Cell receptors ; Cell structures and functions ; Cerebral Cortex - drug effects ; Cerebral Cortex - metabolism ; Dinucleoside Phosphates - pharmacology ; Excitatory Amino Acid Agonists - pharmacology ; Excitatory Amino Acid Antagonists - pharmacology ; Fundamental and applied biological sciences. Psychology ; In Vitro Techniques ; Isoxazoles - pharmacology ; Models, Neurological ; Molecular and cellular biology ; N-Methylaspartate - pharmacology ; Propionates - pharmacology ; Quinoxalines - pharmacology ; Rats ; Receptors, AMPA - agonists ; Receptors, Glutamate - drug effects ; Receptors, Glutamate - metabolism</subject><ispartof>Neurochemistry international, 1996-09, Vol.29 (3), p.309-316</ispartof><rights>1996 Elsevier Science Ltd</rights><rights>1996 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c386t-8cb86873ba64ba1b5c5c23cee1adc119bf5a1ce936658700a0f94923b05caf8f3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3168001$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8885290$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>EBERT, BJARKE</creatorcontrib><creatorcontrib>MADSEN, ULF</creatorcontrib><creatorcontrib>SØBY, KARINA K.</creatorcontrib><creatorcontrib>KROGSGAARD-LARSEN, POVL</creatorcontrib><title>FUNCTIONAL PARTIAL AGONISM AT IONOTROPIC EXCITATORY AMINO ACID RECEPTORS</title><title>Neurochemistry international</title><addtitle>Neurochem Int</addtitle><description>( RS)-2-Amino-3-(3-hydroxy-5-phenyl-4-isoxazolyl)propionic acid (APPA), which is an analogue of ( RS)-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid (AMPA), shows the characteristics of a partial AMPA receptor agonist. Since ( S)-APPA is a full AMPA agonist and ( R)-APPA a competitive antagonist, the partial agonism observed for APPA, which is a 1:1 mixture of ( S)- and ( R)-APPA, is only apparent. These observations have prompted comparative pharmacological studies of different molar ratios of a series of AMPA and N-methyl- d -aspartic acid (NMDA) agonists and respective competitive antagonists, and of these agonists in the presence of fixed concentrations of antagonist. Using the rat cortical wedge preparation, the latter series of experiments showed the expected rightward parallel shifts of the dose-response curves. The former type of experiments, on the other hand, produced dose-response curves at different levels of maximal response, depending on the molar ratios of agonist and antagonist used. This phenomenon, which is in agreement with the theory for competitive receptor interaction, has been termed functional partial agonism, a new pharmacological concept of potential therapeutic utility. These results were obtained using AMPA, the AMPA agonist ( RS)-2-amino-3-(5- tert-butyl-3-hydroxy-4-isoxazolyl)propionic acid (ATPA), the competitive AMPA antagonists ( RS-2-amino-3-(3-carboxymethoxy-5-methyl-4-isoxazolyl)propionic acid (AMOA) and 6-nitro-7-sulfamoylbenzo[ f] quinoxalin-2,3-dione (NBQX), NMDA, and the competitive NMDA antagonist ( RS)-3-(2-carboxy-4-piperazinyl)propyl-1-phosphonic acid (CPP). Copyright © 1996 Elsevier Science Ltd.</description><subject>Alanine - analogs &amp; derivatives</subject><subject>Alanine - pharmacology</subject><subject>Aminoacid receptors (glycine, glutamate, gaba)</subject><subject>Animals</subject><subject>Binding, Competitive - drug effects</subject><subject>Biological and medical sciences</subject><subject>Cell receptors</subject><subject>Cell structures and functions</subject><subject>Cerebral Cortex - drug effects</subject><subject>Cerebral Cortex - metabolism</subject><subject>Dinucleoside Phosphates - pharmacology</subject><subject>Excitatory Amino Acid Agonists - pharmacology</subject><subject>Excitatory Amino Acid Antagonists - pharmacology</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>In Vitro Techniques</subject><subject>Isoxazoles - pharmacology</subject><subject>Models, Neurological</subject><subject>Molecular and cellular biology</subject><subject>N-Methylaspartate - pharmacology</subject><subject>Propionates - pharmacology</subject><subject>Quinoxalines - pharmacology</subject><subject>Rats</subject><subject>Receptors, AMPA - agonists</subject><subject>Receptors, Glutamate - drug effects</subject><subject>Receptors, Glutamate - metabolism</subject><issn>0197-0186</issn><issn>1872-9754</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><recordid>eNp9kNFKwzAUhoMoc07fQKEXInpRTdomTW6EUrutsLWj60CvQpqmUOnW2WyCb2_myi69OnD-7_wcPgBuEXxGEJEXiJhvQ0TJI8NPECKMbO8MDBH1HZv52DsHwxNyCa60_oQQ-gziARhQSrHD4BBMx6skzOM0CWbWIsjy2Mxgkibxcm4FuWWCNM_SRRxa0XsY50GeZh9WMI-T1ArC-M3KojBamOXyGlxUotHqpp8jsBpHeTi1Z-kkDoOZLV1KdjaVBSXUdwtBvEKgAkssHVcqhUQpEWJFhQWSirmEYOpDKGDFPOa4BcRSVLRyR-Dh2Lvt2q-90ju-rrVUTSM2qt1r7lOPUBdTA3pHUHat1p2q-Lar16L74Qjyg0B-sMMPdjjD_E8g98zZXd-_L9aqPB31xkx-3-dCS9FUndjIWp8wFxFqqgz2esSUcfFdq45rWauNVGXdKbnjZVv__8cvQnWFGQ</recordid><startdate>19960901</startdate><enddate>19960901</enddate><creator>EBERT, BJARKE</creator><creator>MADSEN, ULF</creator><creator>SØBY, KARINA K.</creator><creator>KROGSGAARD-LARSEN, POVL</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19960901</creationdate><title>FUNCTIONAL PARTIAL AGONISM AT IONOTROPIC EXCITATORY AMINO ACID RECEPTORS</title><author>EBERT, BJARKE ; MADSEN, ULF ; SØBY, KARINA K. ; KROGSGAARD-LARSEN, POVL</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c386t-8cb86873ba64ba1b5c5c23cee1adc119bf5a1ce936658700a0f94923b05caf8f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Alanine - analogs &amp; derivatives</topic><topic>Alanine - pharmacology</topic><topic>Aminoacid receptors (glycine, glutamate, gaba)</topic><topic>Animals</topic><topic>Binding, Competitive - drug effects</topic><topic>Biological and medical sciences</topic><topic>Cell receptors</topic><topic>Cell structures and functions</topic><topic>Cerebral Cortex - drug effects</topic><topic>Cerebral Cortex - metabolism</topic><topic>Dinucleoside Phosphates - pharmacology</topic><topic>Excitatory Amino Acid Agonists - pharmacology</topic><topic>Excitatory Amino Acid Antagonists - pharmacology</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>In Vitro Techniques</topic><topic>Isoxazoles - pharmacology</topic><topic>Models, Neurological</topic><topic>Molecular and cellular biology</topic><topic>N-Methylaspartate - pharmacology</topic><topic>Propionates - pharmacology</topic><topic>Quinoxalines - pharmacology</topic><topic>Rats</topic><topic>Receptors, AMPA - agonists</topic><topic>Receptors, Glutamate - drug effects</topic><topic>Receptors, Glutamate - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>EBERT, BJARKE</creatorcontrib><creatorcontrib>MADSEN, ULF</creatorcontrib><creatorcontrib>SØBY, KARINA K.</creatorcontrib><creatorcontrib>KROGSGAARD-LARSEN, POVL</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Neurochemistry international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>EBERT, BJARKE</au><au>MADSEN, ULF</au><au>SØBY, KARINA K.</au><au>KROGSGAARD-LARSEN, POVL</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>FUNCTIONAL PARTIAL AGONISM AT IONOTROPIC EXCITATORY AMINO ACID RECEPTORS</atitle><jtitle>Neurochemistry international</jtitle><addtitle>Neurochem Int</addtitle><date>1996-09-01</date><risdate>1996</risdate><volume>29</volume><issue>3</issue><spage>309</spage><epage>316</epage><pages>309-316</pages><issn>0197-0186</issn><eissn>1872-9754</eissn><coden>NEUIDS</coden><abstract>( RS)-2-Amino-3-(3-hydroxy-5-phenyl-4-isoxazolyl)propionic acid (APPA), which is an analogue of ( RS)-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid (AMPA), shows the characteristics of a partial AMPA receptor agonist. Since ( S)-APPA is a full AMPA agonist and ( R)-APPA a competitive antagonist, the partial agonism observed for APPA, which is a 1:1 mixture of ( S)- and ( R)-APPA, is only apparent. These observations have prompted comparative pharmacological studies of different molar ratios of a series of AMPA and N-methyl- d -aspartic acid (NMDA) agonists and respective competitive antagonists, and of these agonists in the presence of fixed concentrations of antagonist. Using the rat cortical wedge preparation, the latter series of experiments showed the expected rightward parallel shifts of the dose-response curves. The former type of experiments, on the other hand, produced dose-response curves at different levels of maximal response, depending on the molar ratios of agonist and antagonist used. This phenomenon, which is in agreement with the theory for competitive receptor interaction, has been termed functional partial agonism, a new pharmacological concept of potential therapeutic utility. These results were obtained using AMPA, the AMPA agonist ( RS)-2-amino-3-(5- tert-butyl-3-hydroxy-4-isoxazolyl)propionic acid (ATPA), the competitive AMPA antagonists ( RS-2-amino-3-(3-carboxymethoxy-5-methyl-4-isoxazolyl)propionic acid (AMOA) and 6-nitro-7-sulfamoylbenzo[ f] quinoxalin-2,3-dione (NBQX), NMDA, and the competitive NMDA antagonist ( RS)-3-(2-carboxy-4-piperazinyl)propyl-1-phosphonic acid (CPP). Copyright © 1996 Elsevier Science Ltd.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>8885290</pmid><doi>10.1016/0197-0186(95)00151-4</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0197-0186
ispartof Neurochemistry international, 1996-09, Vol.29 (3), p.309-316
issn 0197-0186
1872-9754
language eng
recordid cdi_proquest_miscellaneous_78468358
source ScienceDirect Freedom Collection
subjects Alanine - analogs & derivatives
Alanine - pharmacology
Aminoacid receptors (glycine, glutamate, gaba)
Animals
Binding, Competitive - drug effects
Biological and medical sciences
Cell receptors
Cell structures and functions
Cerebral Cortex - drug effects
Cerebral Cortex - metabolism
Dinucleoside Phosphates - pharmacology
Excitatory Amino Acid Agonists - pharmacology
Excitatory Amino Acid Antagonists - pharmacology
Fundamental and applied biological sciences. Psychology
In Vitro Techniques
Isoxazoles - pharmacology
Models, Neurological
Molecular and cellular biology
N-Methylaspartate - pharmacology
Propionates - pharmacology
Quinoxalines - pharmacology
Rats
Receptors, AMPA - agonists
Receptors, Glutamate - drug effects
Receptors, Glutamate - metabolism
title FUNCTIONAL PARTIAL AGONISM AT IONOTROPIC EXCITATORY AMINO ACID RECEPTORS
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T09%3A23%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=FUNCTIONAL%20PARTIAL%20AGONISM%20AT%20IONOTROPIC%20EXCITATORY%20AMINO%20ACID%20RECEPTORS&rft.jtitle=Neurochemistry%20international&rft.au=EBERT,%20BJARKE&rft.date=1996-09-01&rft.volume=29&rft.issue=3&rft.spage=309&rft.epage=316&rft.pages=309-316&rft.issn=0197-0186&rft.eissn=1872-9754&rft.coden=NEUIDS&rft_id=info:doi/10.1016/0197-0186(95)00151-4&rft_dat=%3Cproquest_cross%3E78468358%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c386t-8cb86873ba64ba1b5c5c23cee1adc119bf5a1ce936658700a0f94923b05caf8f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=78468358&rft_id=info:pmid/8885290&rfr_iscdi=true